查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1675347

2025 年至 2033 年腫瘤消融市場報告，按技術（射頻消融、微波消融、冷凍消融等）、治療方式、應用方式、最終用戶和地區分類

Tumor Ablation Market Report by Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, and Others), Mode of Treatment, Mode of Application, End-User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3個工作天內

價格

2024IMARC Group全球腫瘤消融市場規模達到 13.1 億美元。全球癌症發生率的不斷上升、醫療技術的不斷進步以及大眾對微創癌症治療認知的不斷提高是推動市場發展的一些因素。

腫瘤消融是一種醫療程序，涉及移除或破壞異常組織，特別是癌性腫瘤，而無需進行手術切除。這種微創方法採用射頻、雷射、微波或冷凍消融等各種技術，瞄準癌細胞並精準消滅它們。該過程的特點是能夠最大限度地減少對周圍健康組織的損害，從而縮短恢復時間並提高患者的生活品質。這些治療通常由超音波、CT 掃描或 MRI 等影像技術引導，這些技術可以提供即時資料以提高準確性。

全球腫瘤消融市場的發展主要受到全球癌症發生率不斷上升的推動。同時，醫療技術的不斷進步為市場提供了動力。此外，大眾對微創癌症治療認知的不斷增強，也成為推動市場成長的重要因素。此外，人口老化使得人們更容易罹患癌症，這也導致對腫瘤消融療法的投資增加。除此之外，醫療保健系統對減少手術併發症的重視為市場創造了有利可圖的機會。此外，精準醫療的出現也對市場產生了正面影響。醫療保健支出的增加進一步推動了市場的發展，尤其是在已開發國家。其他推動市場發展的因素包括醫療旅遊的興起、先進醫療設施的普及以及廣泛的研發（R&D）活動。

腫瘤消融市場趨勢/促進因素：

以病人為中心的治療方法的興起

現代醫療保健領域越來越注重個人化護理，根據每位患者的獨特需求和情況制定治療方案。這種以患者為中心的轉變徹底改變了腫瘤消融市場。透過設計考慮患者年齡、病史和遺傳傾向等各種因素的治療方法，醫療保健提供者正在製定高度針對性和有效的治療計劃。這種個人化的治療方法對於癌症患者尤其重要，因為由於腫瘤的異質性，癌症患者通常具有獨特的治療反應。透過利用資料分析、基因組學和個人化病史，醫療保健提供者能夠更好地為個別患者選擇最合適的腫瘤消融療法。這種更高程度的個人化不僅提高了治療效果，而且還提高了患者的滿意度和信任度，從而鼓勵更多人選擇腫瘤消融療法。

數位科技日益融合

人工智慧（AI）、機器學習和巨量資料分析等數位技術與醫療保健系統的整合是推動市場擴張的動力。這些技術使醫療保健提供者能夠根據全面的資料分析（包括患者歷史記錄、即時監控和預測模型）做出更明智的決策。這些數位化進步不僅限於患者的診斷和治療計劃。它們還延伸到醫療保健系統的營運方面，簡化管理，降低管理費用，並提高醫療服務的效率。數位技術促進了不同部門甚至不同醫療機構之間的資訊即時共享，從而更容易協調患者護理並根據需要調整治療。這種增強的運作效率不僅改善了患者的治療效果，而且使得採用腫瘤消融療法對於醫療保健系統來說在經濟上更加可行。

主要參與者之間的合作和收購不斷增加

公共和私營部門的投資湧入在塑造市場方面發揮關鍵作用。政府補助、補貼和公共資金為醫療保健領域的研究和發展提供了基礎支持。這些資金使醫學研究人員能夠探索腫瘤消融領域的創新技術，而不必面臨市場可行性的直接壓力。另一方面，通常以創投形式出現的私人投資加速了這些新技術的商業化。公共和私人金融利益的結合往往可以產生突破性的創新，因為它將學術嚴謹性和市場導向方法結合在一起。例如，公共資金可以支持開發新型腫瘤消融技術所需的早期研究，而私人投資可以促進將其推向市場所需的臨床試驗和行銷。這種雙重投資流不僅加速了創新步伐，而且創造了更強勁和充滿活力的市場格局，增強了競爭力，從而推動了市場成長。

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球腫瘤消融市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場區隔：按技術
  • 市場區隔：依治療方式
  • 市場區隔：按應用模式
  • 市場區隔：按最終用戶
  • 市場分佈：按地區
  • 市場預測

第 6 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 7 章：價值鏈分析

第 8 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第9章：市場細分：依技術

  • 射頻消融
  • 微波消融
  • 冷凍消融
  • 其他

第 10 章：市場區隔：依處理方式

  • 經皮消融
  • 腹腔鏡消融術
  • 手術消融

第 11 章：市場區隔：依應用方式

  • 肝癌
  • 肺癌
  • 腎癌
  • 骨轉移
  • 其他

第 12 章：市場區隔：依最終用戶

  • 醫院
  • 癌症專科診所
  • 其他

第 13 章：市場區隔：按地區

  • 北美洲
  • 歐洲
  • 亞太地區
  • 中東和非洲
  • 拉丁美洲

第 14 章：價格分析

第 15 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Medtronic Public Limited Company
    • AngioDynamics Inc.
    • HealthTronics Inc.
    • NeuWave Medical, Inc.
    • INTIO Inc.
    • Galil Medical Ltd
    • Boston Scientific Corporation
    • SonaCare Medical LLC
    • EDAP TMS SA
    • Erbe Elektromedizin GmbH
    • IceCure Medical Ltd
    • MISONIX Inc.
    • Endocare Inc.
    • CooperSurgical Inc.
    • BVM Meditech Pvt
Product Code: SR112025A1629

The global tumor ablation market size reached USD 1,310 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 3,200 Million by 2033, exhibiting a growth rate (CAGR) of 10.4% during 2025-2033. The increasing incidence of cancer cases across the globe, continual advancements in medical technology, and growing awareness about minimally invasive cancer treatments among the masses represent some of the factors that are propelling the market.

Tumor ablation is a medical procedure that involves the removal or destruction of abnormal tissue, particularly cancerous tumors, without the need for surgical excision. Employing various techniques such as radiofrequency, laser, microwave, or cryoablation, this minimally invasive approach targets cancerous cells and eradicates them with precision. The process is characterized by its ability to minimize damage to surrounding healthy tissues, thereby reducing recovery time and improving the patient's quality of life. These treatments are typically guided by imaging technologies such as ultrasound, CT scans, or MRI, which provide real-time data for higher accuracy.

The global market for tumor ablation is primarily driven by the increasing incidence of cancer cases across the globe. In line with this, continual advancements in medical technology are providing an impetus to the market. Moreover, the growing awareness about minimally invasive cancer treatments among the masses is acting as a significant growth-inducing factor for the market. In addition to this, the aging population, which is more susceptible to cancer, is resulting in higher investment in tumor ablation therapies. Besides this, healthcare systems' focus on reducing surgical complications is creating lucrative opportunities in the market. Also, the emergence of precision medicine is positively impacting the market. The market is further propelled by increased healthcare expenditure, particularly in developed countries. Some of the other factors contributing to the market include the rise of medical tourism, greater accessibility to advanced healthcare facilities, and extensive research and development (R&D) activities.

Tumor Ablation Market Trends/Drivers:

Rise in the patient-centric approaches

The modern healthcare landscape is increasingly focusing on personalized care, with treatments being tailored to meet the unique needs and circumstances of each patient. This shift towards patient-centricity has been a game-changer for the tumor ablation market. By designing therapies that consider various patient factors such as age, medical history, and genetic predispositions, healthcare providers are creating highly targeted and effective treatment plans. This personalized approach is particularly important for cancer patients, who often have unique therapeutic responses due to the heterogeneous nature of tumors. By leveraging data analytics, genomics, and personalized medical histories, healthcare providers are better equipped to select the most appropriate tumor ablation therapy for individual patients. This higher degree of personalization not only improves the efficacy of treatments but also increases patient satisfaction and trust, which in turn encourages more people to opt for tumor ablation therapies.

Increasing integration of digital technologies

The integration of digital technologies such as artificial intelligence (AI), machine learning, and big data analytics into healthcare systems is a driving force behind the expansion of the market. These technologies enable healthcare providers to make more informed decisions based on comprehensive data analysis, including patient histories, real-time monitoring, and predictive modeling. These digital advancements are not just limited to patient diagnosis and treatment plans. They also extend to the operational aspects of healthcare systems, streamlining the administration, reducing overhead costs, and improving the efficiency of delivering care. Digital technologies facilitate the real-time sharing of information across different departments or even different healthcare facilities, making it easier to coordinate patient care and adapt treatments as required. This enhanced operational efficiency not only improves patient outcomes but also makes the adoption of tumor ablation therapies more financially viable for healthcare systems.

Rising partnerships and acquisitions amongst key players

The influx of investment from both public and private sectors plays a critical role in shaping the market. Government grants, subsidies, and public funding serve as foundational support for research and development in the healthcare sector. These funds enable medical researchers to explore innovative techniques and technologies in tumor ablation without the immediate pressure of market viability. On the other side, private investment, often in the form of venture capital, accelerates the commercialization process of these new technologies. The alignment of public and private financial interests can often yield breakthrough innovations, as it brings together academic rigor and market-oriented approaches. For instance, public funding can support the early-stage research needed to develop a novel tumor ablation technique, while private investment can facilitate the clinical trials and marketing required to bring it to market. This dual investment stream not only accelerates the pace of innovation but also creates a more robust and dynamic market landscape, fostering competitiveness and, consequently, driving market growth.

Tumor Ablation Industry Segmentation:

Breakup by Technology:

  • Radiofrequency (RF) Ablation
  • Microwave Ablation
  • Cryoablation
  • Others

Radiofrequency (RF) ablation represents the largest market segment

The radiofrequency (RF) ablation segment is primarily driven by its high efficacy rates, shorter procedure times, and minimally invasive nature. Technological advancements have made RF ablation more precise and safe, attracting physicians and patients alike. Moreover, the cost-effectiveness compared to traditional surgical methods has further boosted its adoption. Reimbursement policies have also been favorable, encouraging the use of RF ablation for tumor treatments. Overall, these factors contribute to its major share in the global tumor ablation market.

On the other hand, microwave, cryoablation, and other methods are becoming increasingly popular due to advancements in technology. They offer alternatives to RF ablation but tend to be more expensive and less covered by insurance. Their adoption is also limited by the need for specialized training for healthcare providers. Despite these challenges, they hold a minor but growing segment in the market.

Breakup by Mode of Treatment:

  • Percutaneous Ablation
  • Laparoscopic Ablation
  • Surgical Ablation

Surgical ablation accounts for the majority of the market share

Surgical ablation remains a conventional and highly effective approach for treating various types of tumors. It is often recommended for cases where the tumor is large or not amenable to minimally invasive techniques. Given the invasive nature, surgical ablation usually necessitates longer hospital stays and recovery periods, which can be a downside. However, its proven efficacy and completeness in tumor removal secure its significant role in the global market.

On the other hand, percutaneous and laparoscopic methods are minimally invasive and preferred for small to medium-sized tumors. These techniques are cost-effective but require specialized equipment and training. Their minor market share is partly due to limitations in treating complex or larger tumors. Nonetheless, they remain valuable options in the broader scope of ablation methods.

Breakup by Mode of Application:

  • Liver Cancer
  • Lung Cancer
  • Kidney Cancer
  • Bone Metastasis
  • Others

Liver cancer represents the largest market segment

Liver cancer dominates the global tumor ablation market, largely due to the high incidence and mortality rates associated with this disease. The ablation techniques offer a viable treatment option for early-stage liver cancer, where surgical removal may not be feasible. As liver cancer is often diagnosed at an advanced stage, ablation techniques are viewed as essential palliative treatments. High adoption rates and the emphasis on research for liver cancer ablation contribute to its significant market share.

On the other hand, the other segments including lung, kidney, and bone metastasis are gradually gaining traction due to technological improvements. These cancers are typically treated with other therapies, but ablation is becoming a more common secondary or complementary option. Limitations in insurance coverage and less substantial clinical evidence compared to major segments hold back their market share.

Breakup by End-User:

  • Hospitals
  • Cancer Specialty Clinics
  • Others

Hospitals accounts for the majority of the market share

Hospitals constitute a significant share of the market due to their comprehensive healthcare services and accessibility to a wide patient demographic. They have the financial capability to invest in advanced ablation technologies, and their multidisciplinary teams can offer a variety of treatment options. With the increasing incidence of cancer, hospitals continue to adopt tumor ablation techniques, solidifying their role in the global market.

On the other hand, specialized cancer clinics focus exclusively on cancer treatment, making them ideal centers for advanced ablation therapies. These clinics often have cutting-edge technologies and highly skilled specialists, which makes them attractive for patients seeking specialized care. However, these centers may not be as widespread as hospitals, limiting their accessibility. Their specific focus and expertise, though, contribute to an increasing share in the global market.

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

North America exhibits a clear dominance, accounting for the largest tumor ablation market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America; Europe; Asia Pacific; the Middle East and Africa; and Latin America. According to the report, North America accounted for the largest market share.

North America holds a dominant position in the global market, driven by a number of factors including high healthcare expenditure, advanced medical technologies, and a robust healthcare infrastructure. The region also benefits from favorable reimbursement policies, which make various ablation treatments more accessible to patients. Furthermore, the prevalence of cancer is relatively high in North America, leading to greater demand for effective treatment methods such as tumor ablation.

Research and development (R&D) activities in the region are vigorous, further propelling the adoption of new and improved ablation techniques. Pharmaceutical and medical device companies in North America also contribute to market growth by investing in research, thereby enhancing the technology and its applications. The presence of key market players headquartered in the region adds to the competitive advantage. Educational campaigns and patient awareness programs are also more prevalent here, aiding in early diagnosis and treatment.

Competitive Landscape:

Leaders in the global tumor ablation market are dedicating resources to clinical trials and research to improve the efficacy and safety of their solutions. They are also focusing on developing minimally invasive techniques to cater to patient comfort and faster recovery. Telehealth integrations are in progress to facilitate remote consultations, thereby increasing the adoption rate of their products. Regulatory approvals are a key focus, and as such, these entities are navigating complex compliance landscapes both domestically and internationally. To maintain a competitive edge, alliances with healthcare providers and medical institutions, and implementation of robust after-sales support and training programs are being formed. Furthermore, educational programs for healthcare professionals are being launched to foster proper utilization of the technology.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Medtronic Public Limited Company
  • AngioDynamics Inc.
  • HealthTronics Inc.
  • NeuWave Medical, Inc.
  • INTIO Inc.
  • Galil Medical Ltd
  • Boston Scientific Corporation
  • SonaCare Medical LLC
  • EDAP TMS S.A.
  • Erbe Elektromedizin GmbH
  • IceCure Medical Ltd
  • MISONIX Inc.
  • Endocare Inc.
  • CooperSurgical Inc.
  • B V M Meditech Pvt

Key Questions Answered in This Report

  • 1.What was the size of the global tumor ablation market in 2024?
  • 2.What is the expected growth rate of the global tumor ablation market during 2025-2033?
  • 3.What has been the impact of COVID-19 on the global tumor ablation market?
  • 4.What are the key factors driving the global tumor ablation market?
  • 5.What is the breakup of the global tumor ablation market based on the technology?
  • 6.What is the breakup of the global tumor ablation market based on the mode of treatment?
  • 7.What is the breakup of the global tumor ablation market based on mode of application?
  • 8.What is the breakup of the global tumor ablation market based on the end-user?
  • 9.What are the key regions in the global tumor ablation market?
  • 10.Who are the key players/companies in the global tumor ablation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Tumor Ablation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Technology
  • 5.5 Market Breakup by Mode of Treatment
  • 5.6 Market Breakup by Mode of Application
  • 5.7 Market Breakup by End-User
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast

6 SWOT Analysis

  • 6.1 Overview
  • 6.2 Strengths
  • 6.3 Weaknesses
  • 6.4 Opportunities
  • 6.5 Threats

7 Value Chain Analysis

8 Porter's Five Forces Analysis

  • 8.1 Overview
  • 8.2 Bargaining Power of Buyers
  • 8.3 Bargaining Power of Suppliers
  • 8.4 Degree of Competition
  • 8.5 Threat of New Entrants
  • 8.6 Threat of Substitutes

9 Market Breakup by Technology

  • 9.1 Radiofrequency (RF) Ablation
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Microwave Ablation
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Cryoablation
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Mode of Treatment

  • 10.1 Percutaneous Ablation
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Laparoscopic Ablation
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Surgical Ablation
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Mode of Application

  • 11.1 Liver Cancer
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Lung Cancer
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Kidney Cancer
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast
  • 11.4 Bone Metastasis
    • 11.4.1 Market Trends
    • 11.4.2 Market Forecast
  • 11.5 Others
    • 11.5.1 Market Trends
    • 11.5.2 Market Forecast

12 Market Breakup by End-User

  • 12.1 Hospitals
    • 12.1.1 Market Trends
    • 12.1.2 Market Forecast
  • 12.2 Cancer Specialty Clinics
    • 12.2.1 Market Trends
    • 12.2.2 Market Forecast
  • 12.3 Others
    • 12.3.1 Market Trends
    • 12.3.2 Market Forecast

13 Market Breakup by Region

  • 13.1 North America
    • 13.1.1 Market Trends
    • 13.1.2 Market Forecast
  • 13.2 Europe
    • 13.2.1 Market Trends
    • 13.2.2 Market Forecast
  • 13.3 Asia Pacific
    • 13.3.1 Market Trends
    • 13.3.2 Market Forecast
  • 13.4 Middle East and Africa
    • 13.4.1 Market Trends
    • 13.4.2 Market Forecast
  • 13.5 Latin America
    • 13.5.1 Market Trends
    • 13.5.2 Market Forecast

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Medtronic Public Limited Company
    • 15.3.2 AngioDynamics Inc.
    • 15.3.3 HealthTronics Inc.
    • 15.3.4 NeuWave Medical, Inc.
    • 15.3.5 INTIO Inc.
    • 15.3.6 Galil Medical Ltd
    • 15.3.7 Boston Scientific Corporation
    • 15.3.8 SonaCare Medical LLC
    • 15.3.9 EDAP TMS S.A.
    • 15.3.10 Erbe Elektromedizin GmbH
    • 15.3.11 IceCure Medical Ltd
    • 15.3.12 MISONIX Inc.
    • 15.3.13 Endocare Inc.
    • 15.3.14 CooperSurgical Inc.
    • 15.3.15 B V M Meditech Pvt

List of Figures

  • Figure 1: Global: Tumor Ablation Market: Major Drivers and Challenges
  • Figure 2: Global: Tumor Ablation Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Tumor Ablation Market: Breakup by Technology (in %), 2024
  • Figure 4: Global: Tumor Ablation Market: Breakup by Mode of Treatment (in %), 2024
  • Figure 5: Global: Tumor Ablation Market: Breakup by Mode of Application (in %), 2024
  • Figure 6: Global: Tumor Ablation Market: Breakup by End-User (in %), 2024
  • Figure 7: Global: Tumor Ablation Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Tumor Ablation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Tumor Ablation Industry: SWOT Analysis
  • Figure 10: Global: Tumor Ablation Industry: Value Chain Analysis
  • Figure 11: Global: Tumor Ablation Industry: Porter's Five Forces Analysis
  • Figure 12: Global: Tumor Ablation (Radiofrequency Ablation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Tumor Ablation (Radiofrequency Ablation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Tumor Ablation (Microwave Ablation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Tumor Ablation (Microwave Ablation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Tumor Ablation (Cryoablation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Tumor Ablation (Cryoablation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Tumor Ablation (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Tumor Ablation (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Tumor Ablation (Percutaneous Ablation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Tumor Ablation (Percutaneous Ablation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Tumor Ablation (Laparoscopic Ablation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Tumor Ablation (Laparoscopic Ablation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Tumor Ablation (Surgical Ablation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Tumor Ablation (Surgical Ablation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Tumor Ablation (Liver Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Tumor Ablation (Liver Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Tumor Ablation (Lung Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Tumor Ablation (Lung Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Tumor Ablation (Kidney Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Tumor Ablation (Kidney Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Tumor Ablation (Bone Metastasis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Tumor Ablation (Bone Metastasis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Tumor Ablation (Other Mode of Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Tumor Ablation (Other Mode of Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Tumor Ablation (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Tumor Ablation (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Global: Tumor Ablation (Cancer Specialty Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Global: Tumor Ablation (Cancer Specialty Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Global: Tumor Ablation (Other End-Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Global: Tumor Ablation (Other End-Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: North America: Tumor Ablation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: North America: Tumor Ablation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Europe: Tumor Ablation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Europe: Tumor Ablation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Asia Pacific: Tumor Ablation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Asia Pacific: Tumor Ablation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Middle East and Africa: Tumor Ablation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Middle East and Africa: Tumor Ablation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Latin America: Tumor Ablation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Latin America: Tumor Ablation Market Forecast: Sales Value (in Million USD), 2025-2033

List of Tables

  • Table 1: Global: Tumor Ablation Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Tumor Ablation Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 3: Global: Tumor Ablation Market Forecast: Breakup by Mode of Treatment (in Million USD), 2025-2033
  • Table 4: Global: Tumor Ablation Market Forecast: Breakup by Mode of Application (in Million USD), 2025-2033
  • Table 5: Global: Tumor Ablation Market Forecast: Breakup by End-User (in Million USD), 2025-2033
  • Table 6: Global: Tumor Ablation Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Tumor Ablation Market Structure
  • Table 8: Global: Tumor Ablation Market: Key Players